首页> 外国专利> COMPOSITION AND METHOD FOR ENHANCING PHARMACOLOGICAL ACTIVITY AFTER ORAL AND PARENTERAL ADMINISTRATION OF COMPOSITION COMPRISING POLYPEPTIDE-DRUG SUBSTANCE AND OTHER POORLY ABSORBED ACTIVE INGREDIENT

COMPOSITION AND METHOD FOR ENHANCING PHARMACOLOGICAL ACTIVITY AFTER ORAL AND PARENTERAL ADMINISTRATION OF COMPOSITION COMPRISING POLYPEPTIDE-DRUG SUBSTANCE AND OTHER POORLY ABSORBED ACTIVE INGREDIENT

机译:包含多肽药物和其他吸收不良的活性成分的组合物的口服和腹腔给药后增强药理活性的组合物和方法

摘要

PPROBLEM TO BE SOLVED: To provide new pharmaceutical agents and compositions as well as new methods for enhancing the absorption of polypeptide drug substances that normally display little if any absorbability when administered orally, and also to provide new compositions and methods for significantly enhancing the bioavailability and pharmacological efficacy of polypeptide drug substances whether administered orally or parenterally. PSOLUTION: The method includes generating a prodrug by chemically linking a therapeutic polypeptide of general formula: aan (wherein aa is an amino acid; and n is an integer of 2 to 40) to an alkyl or aryl carrier moiety to form a prodrug, and administering the prodrug to mammals excluding humans exhibiting physiological abnormality. PCOPYRIGHT: (C)2010,JPO&INPIT
机译:

要解决的问题:提供新的药物制剂和组合物以及增强多肽药物吸收的新方法,这些药物通常在口服时几乎不显示吸收性,还提供新的组合物和方法来显着增强多肽药物物质的生物利用度和药理功效,无论是口服还是胃肠外给药。

解决方案:该方法包括通过化学连接通式为aan(其中aa为氨基酸; n为2至40的整数)的治疗性多肽与烷基或芳基载体部分形成前药来形成前药前体药物,并将前体药物给予表现出生理异常的人类以外的哺乳动物。

版权:(C)2010,日本特许厅&INPIT

著录项

  • 公开/公告号JP2009235082A

    专利类型

  • 公开/公告日2009-10-15

    原文格式PDF

  • 申请/专利权人 ZIMMER ROBERT H;

    申请/专利号JP20090137059

  • 发明设计人 ZIMMER ROBERT H;

    申请日2009-06-08

  • 分类号A61K38;A61K47/48;A61P43;A61P25/04;A61K38/22;

  • 国家 JP

  • 入库时间 2022-08-21 19:46:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号